RCM
ZVSAW

Rivernorth Capital Management’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Rivernorth Capital Management’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-206,247
Closed -$25K – 846
2022
Q3 		$25K Buy
+206,247
New +$26.6K ﹤0.01% 614

Rivernorth Capital Management's ZVSAW Position: Q4 2022 in Review

Rivernorth Capital Management sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 206,247 shares — an estimated $25K sold.

Rivernorth Capital Management first reported a position in ZVSAW in Q3 2022 and held it in 1 quarter. The position peaked at $25K in Q3 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

  • Rivernorth Capital Management reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
  • Rivernorth Capital Management sold 206,247 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $25K.
  • Rivernorth Capital Management first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q3 2022 and held it in 1 quarter.
  • Rivernorth Capital Management's ZyVersa Therapeutics, Inc. Warrants position peaked at $25K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Rivernorth Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.